Why Gap Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Shares of The Gap, Inc. GPS jumped in pre-market trading after the company reported better-than-expected financial results for the third quarter on Thursday.

The Gap reported earnings of 59 cents per share, exceeding the analyst consensus estimate of 18 cents. Quarterly sales of $3.767 billion beat the analyst consensus estimate of $3.610 billion, a 7% decrease from sales of $4.039 billion in the same period of 2022, according to data from Benzinga Pro.

Gap shares rose 17.1% to $16.01 in pre-market.

Here are some other stocks moving in pre-market trading.

Gainers

Safe and Green Development Corporation SGD shares rose 150.5% to $7.59 in pre-market trading. Safe And Green Development shares jumped around 559% on Thursday after the company said it does not intend to conduct the offering of the shares of common stock contemplated by the Registration Statement.
Syntec Optics Holdings, Inc. OPTX shares rose 67% to $8.60 in pre-market trading after gaining around 12% on Thursday. Syntec Optics was awarded a contract for optics in biomedical equipment.
Mural Oncology plc MURA shares surged 56.5% to $5.95 in pre-market trading after falling around 92% on Thursday.
BIO-key International, Inc. BKYI shares rose 22.2% to $0.1968 in pre-market trading.
C3is Inc. CISS rose 19.9% to $0.50 in pre-market trading. C3is recently reported third-quarter sales of $10.11 million.
Better Therapeutics, Inc. BTTX shares climbed 18.8% to $0.2020 in pre-market trading. Better Therapeutics recently posted a narrower-than-expected quarterly loss.
Earlyworks Co., Ltd ELWS gained 15.7% to $0.58 in pre-market trading after jumping over 20% on Thursday. Earlyworks recently received Nasdaq notification regarding minimum bid price deficiency.
60 Degrees Pharmaceuticals, Inc. SXTP shares rose 11.8% to $0.7602 in pre-market trading after falling 11% on Thursday. 60 Degrees Pharmaceuticals recently announced that that FDA has granted a Type C meeting to consult on the path forward in developing the tafenoquine regimen of arakoda for hospitalized babesiosis patients.
Marin Software Incorporated MRIN rose 11.2% to $0.32 in pre-market trading after falling around 10% on Thursday. Marin Software recently posted a narrower third-quarter loss.

Losers

Bone Biologics Corporation BBLG dipped 28.3% to $0.5596 in pre-market trading after the company announced a registered direct offering priced at-the-market under Nasdaq rules.
ChargePoint Holdings, Inc. CHPT shares fell 24.3% to $2.37 in pre-market trading after the company reported preliminary results and announced a management transition. The company appointed Rick Wilmer, who has been COO since July 2022, as its new president and CEO, effective Nov. 16.
Alpha Technology Group Limited ATGL shares fell 17.2% to $24.69 in pre-market trading after jumping 136% on Thursday.
KORE Group Holdings, Inc. KORE fell 12.2% to $0.6140 in pre-market after jumping over 58% on Thursday. KORE Group disclosed completion of its previously announced transactions to refinance its approximately $300m term loan.
PaxMedica, Inc. PXMD shares fell 12.4% to $1.77 in pre-market trading after dipping over 16% on Thursday. PaxMedica announced a comprehensive business update along with its financial results for the third quarter.
Aclarion, Inc. ACON shares fell 11.8% to $0.2998 in pre-market trading after jumping over 10% on Thursday.
Infobird Co., Ltd IFBD fell 11.4% to $0.0906 in pre-market trading. Infobird disclosed a 1-for-20 share consolidation and increase of the authorized share capital.
Safety Shot, Inc. SHOT shares fell 10.3% to $2.62 in pre-market trading after jumping 28% on Thursday. Safety Shot said due to spin-off of SRM Entertainment, Limited, the company expects that revenue will decrease from $1,035,762 to about $808,778.
WaveDancer, Inc. WAVD shares fell 9.7% to $2.52 in pre-market trading. WaveDancer shares jumped 85% on Thursday after the company entered an all-stock merger agreement with Firefly Neuroscience.
Innovative Eyewear, Inc. LUCY fell 9.7% to $0.37 in pre-market trading after declining around 5% on Thursday.